Literature DB >> 17899089

Combined effect of Neridronate and specific antibiotic therapy in a case of tuberculous spondylodiscitis.

L Quarta1, A Corrado, N Melillo, A Trotta, G Scotto, F d'Onofrio, N Santoro, F P Cantatore.   

Abstract

Because of the increased incidence of tuberculosis (TB) in recent years, infective spondylitis is still a major problem in the world. In skeletal TB the spine is the most often involved and lumbosacral spine involvement is rare. Nowadays early diagnosis and new medical treatment can reduce the incidence of the serious skeletal sequelae and the number of surgery procedures in spinal TB. We present a case of TB spondylodiscitis characterized by a rapid and progressive clinical and radiological improvement after treatment with Neridronate and chemotherapic drugs. Our data suggest that in the treatment of the TB spondylodiscitis the combined use of these drugs is a good alternative to stimulate bone reparative process to the chemotherapy alone. To our knowledge this is first case of a patient with TB discitis treated with Neridronate. Further studies are necessary to confirm the effectiveness of Neridronate treatment added to antiTB drugs in spondylodiscitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899089     DOI: 10.1007/s00296-007-0460-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  13 in total

1.  Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis.

Authors:  N Kennedy; L Berger; J Curram; R Fox; J Gutmann; G M Kisyombe; F I Ngowi; A R Ramsay; A O Saruni; N Sam; G Tillotson; L O Uiso; M Yates; S H Gillespie
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

2.  Results of nonsurgical treatment of thoracic spinal tuberculosis in adults.

Authors:  Abhay Nene; Shekhar Bhojraj
Journal:  Spine J       Date:  2005 Jan-Feb       Impact factor: 4.166

Review 3.  Bone and joint tuberculosis--a 10-year review.

Authors:  I Grosskopf; A Ben David; G Charach; I Hochman; S Pitlik
Journal:  Isr J Med Sci       Date:  1994-04

4.  A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model.

Authors:  Stephen H Gillespie; Ian Morrissey; Dean Everett
Journal:  J Med Microbiol       Date:  2001-06       Impact factor: 2.472

5.  Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention.

Authors:  Gerald H Mazurek; Margarita E Villarino
Journal:  MMWR Recomm Rep       Date:  2003-01-31

6.  Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.

Authors:  Gerald H Mazurek; John Jereb; Phillip Lobue; Michael F Iademarco; Beverly Metchock; Andrew Vernon
Journal:  MMWR Recomm Rep       Date:  2005-12-16

Review 7.  Spinal infections.

Authors:  E Turgut Tali
Journal:  Eur J Radiol       Date:  2004-05       Impact factor: 3.528

8.  Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption.

Authors:  C Vitté; H Fleisch; H L Guenther
Journal:  Endocrinology       Date:  1996-06       Impact factor: 4.736

9.  Long-term effects of neridronate on human osteoblastic cell cultures.

Authors:  Bruno Frediani; Adriano Spreafico; Caterina Capperucci; Francesca Chellini; Dario Gambera; Paolo Ferrata; Fabio Baldi; Paolo Falsetti; Annalisa Santucci; Luigi Bocchi; Roberto Marcolongo
Journal:  Bone       Date:  2004-10       Impact factor: 4.398

10.  Diphosphonates inhibit human osteoblast secretion and proliferation.

Authors:  M A Khokher; P Dandona
Journal:  Metabolism       Date:  1989-02       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.